Fingerprint
Dive into the research topics of 'High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
Ann W. Silk, Howard L. Kaufman, Brendan Curti, Janice M. Mehnert, Kim Margolin, David McDermott, Joseph Clark, Jenna Newman, Praveen K. Bommareddy, Lisa Denzin, Saltanat Najmi, Azra Haider, Weichung Shih, Michael P. Kane, Andrew Zloza
Research output: Contribution to journal › Article › peer-review
11
Scopus
citations